SCHEMBL13601439

SCHEMBL13601439

CCOC(=O)OC(C)OC(=O)CCN1CCC(C)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TSHR P16473 1/20 0.36
TP53 P04637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 2/20 0.35
MGLL Q99685 1/20 0.35
CHRM2 P08172 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
DRD1 P21728 1/20 0.34
ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601364 0.86 MAPT (0.43) POLBALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL13601528 0.85 TP53 (0.43) POLBHTTALDH1A1KMT2ASMN1; SMN2
SCHEMBL12774140 0.84 TP53 (0.42) ALDH1A1KMT2ASMN1; SMN2TSHRTP53
SCHEMBL13601396 0.81 POLB (0.54) POLBHTTALDH1A1KMT2ASMN1; SMN2
SCHEMBL12774151 0.77 TP53 (0.36) ALDH1A1SMN1; SMN2TP53GAAL3MBTL1
SCHEMBL13601703 0.76 MAPT (0.48) POLBALDH1A1KMT2AKDM4EGAA
SCHEMBL12773998 0.75 CYP2C9 (0.37) ALDH1A1KMT2ASMN1; SMN2TSHRKDM4E
SCHEMBL12842150 0.75 CYP1A2 (0.36) HTTALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL3836410 0.73 LMNA (0.48) ALDH1A1GAALMNAMGLLMAPT
SCHEMBL7277386 0.73 ALDH1A1 (0.44) ALDH1A1GAALMNAMGLLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed